Skip to content
Disclosery

EXANE DERIVATIVES: JOUT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on JOUT, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 5 JOUT shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 5 shares
    Change vs previous 13F -1,263 shares

    <0.01% of the 13F portfolio, value $306.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,268 shares
    Change vs previous 13F -257 shares

    0.03% of the 13F portfolio, value $98,556.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,525 shares
    Change vs previous 13F -497 shares

    0.03% of the 13F portfolio, value $142,872.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,022 shares
    Change vs previous 13F -279 shares

    0.05% of the 13F portfolio, value $213,920.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,301 shares
    Change vs previous 13F -748 shares

    0.06% of the 13F portfolio, value $266,450.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,049 shares
    Change vs previous 13F -1,281 shares

    0.13% of the 13F portfolio, value $435,225.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 4,330 shares
    Change vs previous 13F not available

    0.15% of the 13F portfolio, value $487,665.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).